Cargando…
Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment”
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092875/ https://www.ncbi.nlm.nih.gov/pubmed/37014359 http://dx.doi.org/10.1080/21645515.2023.2195333 |
| _version_ | 1785023450800193536 |
|---|---|
| author | Das, Rituparna Hyer, Randall N. Burton, Paul Miller, Jacqueline M. Kuter, Barbara J. |
| author_facet | Das, Rituparna Hyer, Randall N. Burton, Paul Miller, Jacqueline M. Kuter, Barbara J. |
| author_sort | Das, Rituparna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10092875 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100928752023-04-13 Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment” Das, Rituparna Hyer, Randall N. Burton, Paul Miller, Jacqueline M. Kuter, Barbara J. Hum Vaccin Immunother Coronavirus Taylor & Francis 2023-04-04 /pmc/articles/PMC10092875/ /pubmed/37014359 http://dx.doi.org/10.1080/21645515.2023.2195333 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
| spellingShingle | Coronavirus Das, Rituparna Hyer, Randall N. Burton, Paul Miller, Jacqueline M. Kuter, Barbara J. Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment” |
| title | Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment” |
| title_full | Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment” |
| title_fullStr | Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment” |
| title_full_unstemmed | Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment” |
| title_short | Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment” |
| title_sort | author reply to “heterologous mrna-based covid-19 booster strategies: comment” |
| topic | Coronavirus |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092875/ https://www.ncbi.nlm.nih.gov/pubmed/37014359 http://dx.doi.org/10.1080/21645515.2023.2195333 |
| work_keys_str_mv | AT dasrituparna authorreplytoheterologousmrnabasedcovid19boosterstrategiescomment AT hyerrandalln authorreplytoheterologousmrnabasedcovid19boosterstrategiescomment AT burtonpaul authorreplytoheterologousmrnabasedcovid19boosterstrategiescomment AT millerjacquelinem authorreplytoheterologousmrnabasedcovid19boosterstrategiescomment AT kuterbarbaraj authorreplytoheterologousmrnabasedcovid19boosterstrategiescomment |